BELLUS Health (TSX:BLU) EV-to-Revenue : 108,267.79 (As of May. 13, 2024)

View and export this data going back to 2000. Start your Free Trial

What is BELLUS Health EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BELLUS Health's enterprise value is C$2,057.09 Mil. BELLUS Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 was C$0.02 Mil. Therefore, BELLUS Health's EV-to-Revenue for today is 108,267.79.

The historical rank and industry rank for BELLUS Health's EV-to-Revenue or its related term are showing as below:

TSX:BLU' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.15 Med: 125.82 Max: 4556.58
Current: 103828.07

During the past 13 years, the highest EV-to-Revenue of BELLUS Health was 4556.58. The lowest was -0.15. And the median was 125.82.

TSX:BLU's EV-to-Revenue is not ranked
in the Biotechnology industry.
Industry Median: 7.96 vs TSX:BLU: 103828.07

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-13), BELLUS Health's stock price is C$19.48. BELLUS Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 was C$0.00. Therefore, BELLUS Health's PS Ratio for today is .

BELLUS Health EV-to-Revenue Historical Data

The historical data trend for BELLUS Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BELLUS Health EV-to-Revenue Chart

BELLUS Health Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-Revenue

Get a 7-Day Free Trial

3,238.96

12,262.45

9,463.70

38,031.53

44,037.92

BELLUS Health Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EV-to-Revenue	Get a 7-Day Free Trial															31,329.73	47,946.19	60,288.19	44,037.92	40,022.32

Competitive Comparison of BELLUS Health's EV-to-Revenue

For the Biotechnology subindustry, BELLUS Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BELLUS Health's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BELLUS Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BELLUS Health's EV-to-Revenue falls into.

BELLUS Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BELLUS Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	2057.088	/	0.019
	=	108,267.79

BELLUS Health's current Enterprise Value is C$2,057.09 Mil.
BELLUS Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.02 Mil.

BELLUS Health (TSX:BLU) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BELLUS Health's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	19.48	/	0
	=

BELLUS Health's share price for today is C$19.48.
BELLUS Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00.

BELLUS Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BELLUS Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BELLUS Health (TSX:BLU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BELLUS Health Inc (TSX:BLU) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

275 Armand-Frappier Boulevard, Laval, QC, CAN, H7V 4A7

Website

http://www.bellushealth.com

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, a P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.